This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Accreditation & Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Roger A. Goldberg, MD, MBA
Vitreoretinal Specialist
Bay Area Retina Associates
Walnut Creek, CA
Volunteer Faculty
California Pacific Medical Center
Ophthalmology Residency
San Francisco, CA
Caroline R. Baumal, MD
Professor of Ophthalmology
New England Eye Center
Tufts University School of Medicine
Boston, MA
SriniVas Sadda, MD
President and Chief Scientific Officer
Doheny Eye Institute
Professor of Ophthalmology
University of California – Los Angeles
Geffen School of Medicine
Los Angeles, CA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Roger A. Goldberg, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Genentech, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Aerie Pharmaceuticals, Allergan, Apellis Pharmaceuticals, Carl Zeiss Meditec, Chengdu Kanghong Biotechnology, Genentech, Graybug Vision, Neurotech, Novartis, Ribomics, and Santen. Speaker’s Bureau: Allergan and Genentech.
Caroline R. Baumal, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech, Novartis, and Ora. Speaker's Bureau: Apellis and Regeneron.
SriniVas Sadda, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Amgen, Apellis Pharmaceuticals, Astellas, Bayer, CenterVue, 4DMT, Heidelerg, iveric Bio, Merck, NightStax. Novartis, Optos, Oxurion, Regeneron, and Roche/Genentech. Grant/Research Support: Carl Zeiss Meditec. Speakers Bureau: Carl Zeiss Meditec and Nidek. Research instruments: Carl Zeiss Meditec, CenterVue, Heidelberg, Nidek, Optos, and Topcon.
The Evolve staff, planners, and reviewers have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis Pharmaceuticals.
